BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26033086)

  • 1. Aerosol Delivery in the Treatment of Lung Cancer.
    Storti C; Le Noci V; Sommariva M; Tagliabue E; Balsari A; Sfondrini L
    Curr Cancer Drug Targets; 2015; 15(7):604-12. PubMed ID: 26033086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerosolized chemotherapy.
    Gagnadoux F; Hureaux J; Vecellio L; Urban T; Le Pape A; Valo I; Montharu J; Leblond V; Boisdron-Celle M; Lerondel S; Majoral C; Diot P; Racineux JL; Lemarie E
    J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):61-70. PubMed ID: 18518832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination.
    Laube BL
    Respir Care; 2005 Sep; 50(9):1161-76. PubMed ID: 16122400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosol therapy for malignancy involving the lungs.
    Rao RD; Markovic SN; Anderson PM
    Curr Cancer Drug Targets; 2003 Aug; 3(4):239-50. PubMed ID: 12871055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities.
    Mangal S; Gao W; Li T; Zhou QT
    Acta Pharmacol Sin; 2017 Jun; 38(6):782-797. PubMed ID: 28504252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The airways, a novel route for delivering monoclonal antibodies to treat lung tumors.
    Maillet A; Guilleminault L; Lemarié E; Lerondel S; Azzopardi N; Montharu J; Congy-Jolivet N; Reverdiau P; Legrain B; Parent C; Douvin DH; Hureaux J; Courty Y; De Monte M; Diot P; Paintaud G; Le Pape A; Watier H; Heuzé-Vourc'h N
    Pharm Res; 2011 Sep; 28(9):2147-56. PubMed ID: 21491145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhaled chemotherapy - Part 1: General concept and current technological challenges].
    Rosière R; Hureaux J; Levet V; Amighi K; Wauthoz N
    Rev Mal Respir; 2018 Apr; 35(4):357-377. PubMed ID: 29731372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The re-emergence of aerosol gene delivery: a viable approach to lung cancer therapy.
    Densmore CL
    Curr Cancer Drug Targets; 2003 Aug; 3(4):275-86. PubMed ID: 12871058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulations for pulmonary administration of anticancer agents to treat lung malignancies.
    Carvalho TC; Carvalho SR; McConville JT
    J Aerosol Med Pulm Drug Deliv; 2011 Apr; 24(2):61-80. PubMed ID: 21410326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhalation delivery and anti-tumor activity of celecoxib in human orthotopic non-small cell lung cancer xenograft model.
    Fulzele SV; Chatterjee A; Shaik MS; Jackson T; Singh M
    Pharm Res; 2006 Sep; 23(9):2094-106. PubMed ID: 16902813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerosolized Medications for Gene and Peptide Therapy.
    Laube BL
    Respir Care; 2015 Jun; 60(6):806-21; discussion 821-4. PubMed ID: 26070576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in aerosol gene delivery systems using non-viral vectors for lung cancer therapy.
    Lee AY; Cho MH; Kim S
    Expert Opin Drug Deliv; 2019 Jul; 16(7):757-772. PubMed ID: 31282221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aerosol azacytidine inhibits orthotopic lung cancers in mice through Its DNA demethylation and gene reactivation effects.
    Qiu X; Liang Y; Sellers RS; Perez-Soler R; Zou Y
    PLoS One; 2014; 9(10):e109874. PubMed ID: 25347303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug.
    Garbuzenko OB; Saad M; Betigeri S; Zhang M; Vetcher AA; Soldatenkov VA; Reimer DC; Pozharov VP; Minko T
    Pharm Res; 2009 Feb; 26(2):382-94. PubMed ID: 18958402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhaled chemotherapy - Part 2: Clinical practice and potential applications].
    Rosière R; Hureaux J; Levet V; Amighi K; Wauthoz N
    Rev Mal Respir; 2018 Apr; 35(4):378-389. PubMed ID: 29731374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Camptothecins and lung cancer: improved delivery systems by aerosol.
    Koshkina NV; Waldrep JC; Knight V
    Curr Cancer Drug Targets; 2003 Aug; 3(4):251-64. PubMed ID: 12871056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery of transferrin-conjugated liposomes to an orthotopic model of lung cancer in nude rats.
    Gaspar MM; Radomska A; Gobbo OL; Bakowsky U; Radomski MW; Ehrhardt C
    J Aerosol Med Pulm Drug Deliv; 2012 Dec; 25(6):310-8. PubMed ID: 22857016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.
    Koshkina NV; Kleinerman ES; Waidrep C; Jia SF; Worth LL; Gilbert BE; Knight V
    Clin Cancer Res; 2000 Jul; 6(7):2876-80. PubMed ID: 10914737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 9-Nitrocamptothecin liposome aerosol treatment of human cancer subcutaneous xenografts and pulmonary cancer metastases in mice.
    Knight V; Kleinerman ES; Waldrep JC; Giovanella BC; Gilbert BE; Koshkina NV
    Ann N Y Acad Sci; 2000; 922():151-63. PubMed ID: 11193890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.